1. Home
  2. ZCMD vs VRAX Comparison

ZCMD vs VRAX Comparison

Compare ZCMD & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zhongchao Inc.

ZCMD

Zhongchao Inc.

HOLD

Current Price

$0.91

Market Cap

2.0M

Sector

Real Estate

ML Signal

HOLD

Logo Virax Biolabs Group Limited

VRAX

Virax Biolabs Group Limited

HOLD

Current Price

$2.90

Market Cap

2.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZCMD
VRAX
Founded
2012
2013
Country
China
United Kingdom
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0M
2.3M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
ZCMD
VRAX
Price
$0.91
$2.90
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$1.00
AVG Volume (30 Days)
3.1M
467.8K
Earning Date
04-28-2026
06-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$217,274.83
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.02
$0.10
52 Week High
$11.96
$13.19

Technical Indicators

Market Signals
Indicator
ZCMD
VRAX
Relative Strength Index (RSI) 46.02 50.09
Support Level $0.54 $0.19
Resistance Level $0.97 $3.10
Average True Range (ATR) 0.10 0.28
MACD -0.00 -0.03
Stochastic Oscillator 47.17 13.92

Price Performance

Historical Comparison
ZCMD
VRAX

About ZCMD Zhongchao Inc.

ZHONGCHAO Inc is an offshore holding company. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provides healthcare information, education, and training services to healthcare professionals under its MDMOOC brand. It also provides focused patient management services through the Zhongxun IT system and WeChat mini program, and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the detection of immune responses and the development of immune profiling and in vitro diagnostic technologies for viral and immune-mediated diseases, with a current strategic focus on post-acute infection syndromes (PAIS) and related areas of chronic immune dysfunction. The company's principal development activities are centered on T cell-based in vitro diagnostics and immune profiling. The company's flagship product candidate, ViraxImmune, is an in-development T cell-based assay and immune profiling platform intended to support the assessment of immune dysfunction, initially in PAIS indications.

Share on Social Networks: